Lutathera (lutetium 177 dotatate)

pCPA File Number: 22028

Negotiation Status:

Concluded with an LOI

Indication(s):

Unresectable or metastatic, well-differentiated, somatostatin receptor (SSR)–positive pancreatic neuroendocrine tumours (pNETs) in adults whose disease has progressed after treatment with a somatostatin analogue (SSA), unless there is a contraindication or intolerance

Sponsor/Manufacturer:

Advanced Accelerator Applications

CDA-AMC Project Number:

PC0284-000

pCPA Engagement Letter Issued:

2023-04-24

Negotiation Process Concluded:

2023-10-17